Subscribe
Summit Preview

Pandemic Response Webcast Series

A series of virtual Executive Briefings
Next discussion – Tuesday, July 21, 10–11 a.m.PT/1–2 p.m. ET

The Pandemic Response Series features insights from federal and state government officials, leading health care provider, payer and life science CEOs on best practices for mitigation, management of outbreaks and collaborations with public health infrastructure. Executives provide lessons learned thus far from the front lines, shed light on available diagnostics, treatments, forthcoming vaccines and discuss necessary conditions to chart a path out of the crisis.

Pandemic Response Series Schedule
July 21 – COVID-19 Therapeutic Innovation: Regulatory Policymaking and Expedited Clinical Trial Innovation
Powered by Siemens Healthineers

Emcee: David Brailer, MD, Executive Chairman, Health Evolution
Host: Bernd Montag, CEO, Siemens Healthineers; Partner Committee

Discussion Leaders:
Patrizia Cavazzoni, MD, Acting Director, Center for Drug Evaluation and Research, FDA
Esther Krofah, Executive Director, FasterCures, Milken Institute
Ramona Sequeira, President, Takeda Pharmaceuticals USA, Takeda; Confab Committee

• Impact of regulatory policymaking to expedite development of therapeutics
• Update on promising therapeutics, supply chain innovations and timeline for broad distribution as well as therapeutic priorities, initiatives, challenges
• Addressing vaccine hesitancy and equitable distribution
• Innovative public-private collaboration to prioritize therapeutic candidates, streamline clinical trial activity, and access resources across all stakeholders
• Addressing delays in clinical trial enrollment caused by the global pandemic and steps organizations can take to expedite enrollment
• Lessons learned to leverage the pandemic mindset and overcome barriers post-COVID and facilitate more agile, speedier processes
July 28 – Payer CEO Insights: New Directions for Virtual Health and Payer-Provider Relationships
Powered by TripleTree

Host: Justin Roth, Head of Investment Banking, TripleTree

Discussion Leaders:
David Holmberg, President & CEO, Highmark Health
• Additional discussion leaders TBA
August 4 – Confronting Racial Disparities and the Drivers of Health During COVID-19
Powered by AmeriHealth Caritas

Host: Paul Tufano, Chairman & CEO, AmeriHealth Caritas; Partner Committee

Discussion Leaders:
Wright Lassiter, III, President & CEO, Henry Ford Health System
• Additional discussion leaders TBA

August 18 – Financial Impact of COVID-19 on Health Systems
Powered by Lazard

Host: Peter Orszag, CEO of Financial Advisory, Lazard

Discussion Leaders:
Marna Borgstrom, President & CEO, Yale New Haven Health; Board of Trustees, AHA
• Additional discussion leaders TBA

• How leading health systems are addressing severe financial risks, and executing on cost reduction and efficiency initiatives
• Improving the financial stability of health systems including capital markets and debt ratings and financing options
• Impact of the pandemic on future investments and capital capacity

September 1 – The Global Health Care Supply Chain—COVID-19 and the New Landscape
Emcee: David Brailer, MD, Executive Chairman, Health Evolution

Discussion Leaders:
George Barrett, former Chairman & CEO, Cardinal Health; Member of the Board of Directors, Target
Marc Casper, President & CEO, Thermo Fisher Scientific
Kieran Murphy, President & CEO, GE Healthcare

• Assessment of the availability of medical equipment and supplies in comparison to March and April, 2020
• Examining how the global supply chain evolved and how industries are adapting to build resilience
• The implications of other factors on the global supply chain, including medical system changes, consumer behavior, and geopolitical dynamics
September 8 – COVID’s Lasting Impact on Care Delivery Models
Powered by CareCentrix

Host: John Driscoll, CEO, CareCentrix

Discussion leaders: TBD

• Impact of COVID on alternative care models, value-based care, telehealth, retail care and home care
September 15 – Powering Pandemic Response: Innovation
Host: TBA

Discussion Leaders:
Karen Lynch, EVP, CVS Health and President, Aetna
• Additional discussion leaders TBA

• Impact of the crisis on data-driven innovation in consumer-focused solutions, chronic care management, and processes for managing spectrum of COVID care
October 13 – The Race for a Vaccine: Regulatory Policymaking and Expedited Clinical Trial Innovation
Host: TBA

Discussion Leaders:
Peter Marks, MD, Director, Center for Biologics Evaluation and Research, FDA
• Additional Discussion LeadersTBA

• Impact of regulatory policymaking to expedite development of vaccines
• Update on promising vaccines, supply chain innovations and timeline for broad distribution
• Innovative public-private collaboration to prioritize vaccine candidates, streamline clinical trial activity, and access resources across all stakeholders

For content themes and thought leader suggestions, please email Nicole Garratt at NicoleG@healthevolution.com.


To register for ALL of the Pandemic Response series webcasts, complete this form:


On-demand Recordings
Watch the on-demand recordings from our past virtual gatherings:

May 19 – COVID Phase 2: Charting a Path Out of the Crisis:


April 1 – Pandemic Response: A Public-Private Call to Action: